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I N T RODUC T I ON
Members of the CLC Cl channel/transporter family 
participate in a wide spectrum of biological processes 
from extreme acid resistance in enteric bacteria to lyso-
somal acidification and membrane voltage regulation 
in mammalian cells (Jentsch, 2008; Jentsch et al., 2005; 
Stauber et al., 2012). These CLC proteins contain two 
identical subunits (Middleton et al., 1994, 1996; Ludewig 
et al., 1996), each forming a Cl-transport pathway 
(Dutzler et al., 2002, 2003). In eukaryotic CLC Cl 
channels, such as CLC-0 and CLC-1, the individual 
anion-transport pathways (or pores) are gated by the 
negatively charged side chain of a glutamate residue 
(Dutzler et al., 2003). The swing of this glutamate side 
chain is believed to be responsible for the “fast gating” 
operating in the time range of milliseconds. There is a 
second gating mechanism called “slow gating” (for 
CLC-0) or “common gating” (for CLC-1), which con-
trols the opening and closing of both pores simultane-
ously with a slower kinetics (Chen, 2005; Miller, 1982; 
Miller and White, 1984). Although recent work has 
identified certain molecular determinants for the slow/
common gating of CLC channels (Bennetts and Parker, 
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2013), the exact mechanism of this gating process is not 
well understood.
It has been suggested that interactions between the 
two CLC subunits are involved in the slow/common 
gating processes (Estévez and Jentsch, 2002; Bykova 
et al., 2006). Crystal structures of the Escherichia coli CLC 
(CLC-ec1) and a eukaryotic CLC transporter CmCLC 
show extensive helix packing in the subunit interface 
(Dutzler et al., 2002; Feng et al., 2010; Robertson et al., 
2010). At this flat, nonpolar interface, hydrophobic res-
idues such as valine, leucine, and isoleucine form most 
of the cross-subunit contacts (Dutzler et al., 2002; 
Robertson et al., 2010). Replacing two isoleucine resi-
dues, I201 and I422, at the dimer interface of CLC-ec1 
(see Fig. 1 for the locations of these two residues) with 
tryptophan disrupts the dimeric architecture, and the 
I201W/I422W double mutant of CLC-ec1 exists as a 
monomer (Robertson et al., 2010). Coincidentally, pre-
vious work has also demonstrated that mutations of 
I290 and I556 of CLC-1 (which correspond to I201 and 
I422, respectively, in CLC-ec1) alter the common gating 
(Pusch et al., 1995; Kubisch et al., 1998; Saviane et al., 
1999). Collectively, these results suggest that molecular 
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because of its inhibition on the slow gating. We identified CLC-0 residues C229 and H231, located at the intra-
cellular end of the transmembrane domain near the dimer interface, as the Cd2+-coordinating residues. The inhibi-
tion of the current of CLC-0 by Cd2+ was greatly enhanced by mutation of I225W and V490W at the dimer interface. 
Biochemical experiments revealed that formation of a disulfide bond within this Cd2+-binding site is also affected 
by mutation of I225W and V490W, indicating that these two mutations alter the structure of the Cd2+-binding site. 
Kinetic studies showed that Cd2+ inhibition appears to be state dependent, suggesting that structural rearrange-
ments may occur in the CLC dimer interface during Cd2+ modulation. Mutations of I290 and I556 of CLC-1, which 
correspond to I225 and V490 of CLC-0, respectively, have been shown previously to cause malfunction of CLC-1 
Cl channel by altering the common gating. Our experimental results suggest that mutations of the corresponding 
residues in CLC-0 change the subunit interaction and alter the slow gating of CLC-0. The effect of these muta-
tions on modulations of slow gating of CLC channels by intracellular Cd2+ likely depends on their alteration of 
subunit interactions.
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496 Cadmium modulation in CLC channels
EGTA, and various salts for electrophysiological recordings were 
from Sigma-Aldrich and Thermo Fisher Scientific.
Mutagenesis and channel expression
The CLC-0 and CLC-1 cDNAs used for electrophysiological record-
ings were constructed in the pcDNA3 vector without any genetic 
tags of fluorescent proteins. For the constructs used in biochemical 
experiments, a “Flag” epitope was added to the N terminus (after 
the first methionine) of different CLC-0 constructs subcloned in 
the pcDNA3 vector. Mutations were made using the QuikChange 
site-directed mutagenesis kit (Agilent Technologies) and were con-
firmed by commercial DNA sequencing services. In the fluorescent 
resonant energy transfer (FRET) study used to evaluate the inter-
action of two channel subunits (Fig. 3), the C-terminal cytoplasmic 
domain of CLC-0 was removed after Ser530 to make a fair compari-
son with CLC-ec1 because the latter lacks a cytoplasmic domain. 
This C terminus–truncated mutant of CLC-0, referred to as CLC0-
TM, has been described previously (Bykova et al., 2006). It was con-
structed in the pEGFP-N3 vector, and the C terminus of the 
CLC0-TM sequence was tagged by a Gly-Ser linker followed by the 
sequence of cerulean or eYFP. The I225W/V490W mutations of 
CLC-0 (corresponding to I201W/I422W mutations in CLC-ec1) 
were made in these two CLC0-TM constructs, and were used in the 
FRET study. The CNG channel used as the negative control in the 
FRET experiment was provided by W.N. Zagotta (University of 
Washington, Seattle, WA), and fluorescent proteins were also 
tagged to the C terminus of the CNG channel.
All experiments on WT CLC-0 and its mutants were conducted 
in human embryonic kidney (HEK)293 cells, whereas experi-
ments on WT and mutant CLC-1 were conducted in tsA201 cells. 
Transfections of cDNA into HEK293 cells or tsA201 cells followed 
a procedure described previously (Lin and Chen, 2003; Zhang 
et al., 2006, 2010; Zhang and Chen, 2009), using the lipofectamine 
transfection kit (Life Technologies). Experiments were performed 
1–3 d after transfections.
Electrophysiological recordings
Constructs of WT or mutant CLC channels were cotransfected 
with the cDNA of the green fluorescent protein (GFP). The green 
fluorescence was visualized via an inverted microscope (DM IRB; 
Leica) equipped with a GFP filter (Chroma Technology Corp.). 
Macroscopic currents from excised inside-out membrane patches 
of the transfected cells were recorded according to methods de-
scribed previously (Lin and Chen, 2003; Zhang et al., 2006, 2010; 
events occurring in the CLC dimer interface contribute 
to slow/common gating.
The research in our laboratory has revealed previ-
ously that extracellular zinc ions (Zn2+) inhibit CLC-0 
by facilitating the closure of slow gate, although the 
Zn2+-binding site for this effect is not known (Chen, 
1998). In the present study, we find that intracellular 
transition metal cations (such as Cd2+) also inhibit the 
slow gating in WT CLC-0. We have identified that the 
Cd2+-binding site responsible for this inhibition effect in 
CLC-0 is formed by C229 and H231 located at the dimer 
interface near the intracellular end of the transmem-
brane domain (Fig. 1). Interestingly, the Cd2+ inhibi-
tion potency in CLC-0 is drastically increased by I225W/
V490W mutations, corresponding to the dimer inter-
face mutations of I201W/I422W in CLC-ec1. In addi-
tion, formation of a disulfide bond between introduced 
cysteine residues in this binding site is also affected by 
mutations of I225W and V490W. These results show 
that a structural change of the Cd2+-binding site, as re-
ported by the alterations of Cd2+ modification and disul-
fide-bond formation, is induced by the dimer interface 
mutations, which also alter CLC channel’s slow/common 
gating. These results thus suggest that a structural rear-
rangement at the dimer interface near the intracellular 
Cd2+-binding site is likely involved in the slow/common 
gating of CLC channels.
MAT E R I A L S  AND  M E THOD S
Chemicals
MTS reagents were purchased from Toronto Research Chemi-
cals. Stock solutions of 0.3 M MTS reagents were made in distilled 
water and stored at 80°C. The working solutions with required 
concentrations of MTS reagents were made immediately before 
use from the stock solution placed on ice, and were discarded if 
not used within 5 min. Cadmium chloride (CdCl2), HEPES, 
Figure 1. Crystal structure of CLC-ec1 as a guid-
ing roadmap for examining the transmembrane 
domains of CLC-0 and CLC-1. The residues R205 
(yellow) and Q207 (green) of CLC-ec1 corre-
spond to C229 and H231 of CLC-0, or S294 and 
Y296 of CLC-1, respectively. Residues I201 (blue) 
and I422 (purple) are also depicted, which cor-
respond to I225 and V490 of CLC-0, or I290 and 
I556 of CLC-1, respectively. The double muta-
tions I201W/I422W in CLC-ec1 disrupted the 
dimeric interaction in this E. coli CLC and gen-
erated functional monomeric CLC-ec1 proteins 
(Robertson et al., 2010).
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applied to the intracellular side of the excised inside-out mem-
brane patches.
Examining the kinetics of Cd2+ inhibition on the I225W/
V490W mutant is challenging because monitoring the channel 
current requires negative voltage pulses that relieve the binding 
of the Cd2+. We therefore designed a two-pulse protocol for study-
ing the kinetics of Cd2+ inhibition. To evaluate the inhibition 
rate of intracellular Cd2+, a 100-mV voltage pulse for 50 ms 
was first given to obtain the initial current in the absence of 
Cd2+, followed by exposing the patch to various concentrations 
of Cd2+ at 0, 40, or 80 mV for various periods of time before 
the same pulse was given again to measure the remaining cur-
rent (Fig. 12 A). Combining multiple traces from experiments 
using this two-pulse protocol generates the time course of the 
Cd2+ inhibition (Fig. 12 B). To measure the recovery rate of 
Cd2+ inhibition, a 50-ms voltage pulse to 100 mV was given to 
obtain the control current, followed by exposing the patch to 
300 µM Cd2+ for 2 s. Cd2+ was then washed out for various 
amounts of time at 0, 40, or 80 mV before a second voltage 
pulse was given to assess the current. The current recorded from 
the second pulse was normalized to the control current before 
Cd2+ inhibition.
All solution exchanges were achieved by using a solution ex-
changer (SF-77; Warner Instruments). The time for the electrode 
tip to cross the border of two laminar flows from the solution de-
livery pipe of the exchanger is only 2 ms (Zhang and Chen, 2009). 
Including the dead time of triggering the motor that moves the 
solution delivery pipes, the solution exchange is usually com-
pleted within 20–50 ms.
FRET experiments and analyses
Experimental methods for the FRET experiments have been de-
scribed previously (Bykova et al., 2006). In brief, an inverted fluo-
rescence microscope (IX-81; Olympus) equipped with a 100-W 
mercury lamp was used for imaging. The intensity of the excita-
tion light was controlled by a set of neutral density filters installed 
in a filter wheel, and the duration of light exposure was con-
trolled by a computer-driven mechanical shutter (IX2-SHA; 
Olympus) using Metamorph software (Molecular Devices). The 
cell images and the images of their spectra were recorded by a 
CCD camera (128B; Roper Scientific). For FRET measurements, 
two filter cubes (Chroma Technology Corp.) were used: Cube I 
(excitation filter D436/20 and dichroic mirror 455dclp) was used 
to excite cerulean; Cube II (excitation filter HQ500/20 and di-
chroic mirror Q515lp) was used to excite eYFP. No emission filter 
was used in these cubes. Autofluorescence from untransfected 
cells was negligible in all experiments.
Fluorescence imaging and analysis were performed using the 
Metamorph software (Molecular Devices). The experiments were 
achieved by user-designed journals that initiated automatic col-
lection of a bright field cell image, the fluorescence cell images 
(taken with 50 ms of light exposure), and finally the spectral im-
ages (800 ms of light exposure). Spectral images were generated 
from the fluorescence signal on the cell by passing the imaging 
through a slit of a spectrograph (Acton SpectraPro 2150i; Prince-
ton Instruments; Fig. 3 A); the same slit position was applied to 
both the spectrum from cerulean excitation and the spectrum 
from eYFP excitation. Fluorescence signals from the truncated 
WT CLC-0 and the truncated I225W/V490W mutant can be clearly 
identified at the membrane (Fig. 3 A). Therefore, the edge of the 
spectra corresponding to the membrane fluorescent signal was 
used for FRET analysis. Background light spectra, collected from 
the blank region of the same image, were subtracted from the 
cerulean and the eYFP spectral signals.
FRET involves a nonradiative transfer of light-induced excita-
tion from one fluorophore (donor) to another (acceptor) when 
the donor and acceptor are located within a distance of <100 Å 
Zhang and Chen, 2009). Both Cd2+ and Zn2+ (not depicted) can 
inhibit WT CLC-0 from the intracellular side with roughly similar 
potency. However, Zn2+ inhibition on the I225W/V490W mutant 
has a slower off-rate compared with that of the Cd2+ inhibition. 
Thus, for technical convenience, we focused on the experiments 
using Cd2+. All electrophysiological experiments were conducted 
using an amplifier (Axopatch 200B; Molecular Devices), and the 
recording traces were digitally filtered at 5 kHz, and digitized at 
10 kHz using a Digidata 1440 digitizing board and pClamp10 soft-
ware (Molecular Devices). The recording pipettes were fabricated 
from borosilicate glass capillaries (World Precision Instruments) 
using the pp830 pipette puller (Narishige International, Inc.). 
The electrodes normally had a resistance of 1–3 MΩ when filled 
with the pipette (extracellular) solution containing (mM): 130 
NaCl, 5 MgCl2, 10 HEPES, and 1 EGTA, pH 7.4. The bath (intra-
cellular) solution was the same as the pipette solution except that 
EGTA was not included in the solution containing Cd2+. Because 
the two gating mechanisms in WT CLC-0 operate in very different 
time scales (Miller, 1982; Miller and White, 1984; Maduke et al., 
2000; Chen, 2005), a voltage protocol containing multiple short 
voltage steps was used to construct the voltage-dependent activa-
tion curve (which reflects the fast-gate Po-V curve): a prepulse at 
60 mV was given before the test voltage was clamped from 60 to 
160 mV for 100 ms in 20-mV voltage steps, followed by a tail 
voltage pulse at 100 mV. The voltage-dependent fast-gate activa-
tion curve was constructed by normalizing the initial tail current 
after various test voltages to that after the most depolarized test 
voltage. For the hyperpolarization-activated mutants such as the 
I225W/V490W double mutant and the mutants constructed in 
the I225W/V490W background, the voltage protocol included a 
test voltage pulse from 60 to 160 mV for 40 ms in 10-mV steps 
followed by a 100-mV tail pulse. The P/4 leak subtraction rou-
tine was applied to the recordings of the hyperpolarization- 
activated mutants because no current was detected from these 
mutants at the membrane voltage >0 mV.
The kinetics of the two gating mechanisms of CLC-1 (fast gat-
ing and common gating) only differs by severalfold. Separating 
these two gating mechanisms normally relies on two voltage pro-
tocols (referred to as protocol A and protocol B; Accardi and 
Pusch, 2000; Duffield et al., 2003; Bennetts et al., 2005; Tseng 
et al., 2007). Protocol A was used to assess the overall open prob-
ability (Po) of CLC-1: the product of the open probability of the 
fast gate (Pof) and that of the common gate (Poc). In brief, the 
membrane voltage was clamped at 0 mV and was first stepped to 
various test voltages from 120 to 120 mV in 20-mV steps for 
200 ms before the tail voltage step at 100 mV for 100 ms. The 
tail current at 100 mV was fitted to a double exponential func-
tion, and the Po was calculated by normalizing the value of the 
initial tail current to the maximal initial tail current obtained 
after the most positive test voltage. Protocol B is basically the 
same as protocol A except that a short (400-µs) but very positive 
(170-mV) pulse was inserted before the tail voltage step to com-
pletely open the fast gate. In this case, the normalized tail current 
represents Poc at the preceding test voltage, and Pof can be calcu-
lated by dividing Po by Poc.
In experiments where continuous monitoring of the channel 
current was required, the membrane potential was clamped at 
0 mV. For the depolarization-activated channels (such as WT 
CLC-0, C212S, and CLC-1), a voltage pulse of 60 mV for 100–200 ms 
followed by a negative voltage of 100 mV for 100–300 ms was 
given every 2 s. For the hyperpolarization-activated mutants, the 
60-mV voltage step of this pulse protocol was omitted. The steady-
state current at the end of the negative voltage step was mea-
sured to monitor the various effects from Cd2+ modulation or 
from modification by MTS reagents. Solution exchange was 
achieved using a solution exchanger (SF-77; Warner Instru-
ments). Various concentrations of Cd2+ or MTS reagents were 
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and eYFP. The resulted spectrum only contains emission from the 
acceptor (eYFP), which includes two components: the eYFP emis-
sion caused by FRET (FY(FRET)436) and the emission caused by di-
rect excitation of eYFP (FY(Direct)436). Thus,
 Ratio A  F F F  F FY436
Y
5
Y FRET
436
Y Direct
436
Y
5= = +( )( ) ( )00 00 .  
We defined FRET ratio (FR) as the ratio of A and A0:
 
FR Ratio A/Ratio A
F  F FY FRET 436
Y Direct
436
Y Direct
= =
+( )( ) ( ) (
0
/ ) ( ) ( )= +436
Y FRET
436
Y Direct
4361 F F/ .
 
The apparent FRET efficiency (Eapp) is calculated according to:
 E FR 1app Y C= ( )× −( )ε ε ,  
where C and Y are molar extinction coefficients of cerulean and 
eYFP, respectively.
Biochemical experiments and Western blots
The Flag-tagged CLC-0 constructs were transfected into HEK293 
cells, and the cells were harvested 2 d after transfection. The har-
vested cells were lysed in Dulbecco’s phosphate-buffered saline 
(Life Technologies) containing 25 mM 3-[(3-cholamidopropyl) 
dimethylammonio]-1-propanesulfonate (CHAPS) and a protease 
inhibitor cocktail (Roche). The supernatant of the lysate after 
centrifugation was treated with or without 10 µM copper phen-
anthroline before being loaded into a 7.5% SDS-PAGE gel for 
(Miyawaki and Tsien, 2000; Erickson et al., 2001; Zheng et al., 
2002, 2003). The efficiency of the energy transfer (E) depends 
on the distance, R, between the two fluorophores following the 
Forster equation:
 E  R R R6= ( ) ( ) + 0
6
0
6 ,  
where R0 is a spectroscopically determined distance when E = 0.5 
(or 50% of FRET efficiency). Our FRET experiments involved 
passing fluorescence signal of the cell through a slit of a spectro-
graph and obtaining the spectrum of the fluorescence (Fig. 3 A). 
The spectra obtained by using the cerulean excitation wavelength 
(wavelength centered at 436 nm) and that obtained by using the 
eYFP excitation wavelength (wavelength centered at 500 nm) 
were from cells transfected with constructs containing cerulean 
and eYFP, or from cells transfected with constructs containing 
eYFP only. FRET efficiency was calculated using the method and 
equations demonstrated in Bykova et al. (2006). The FRET analy-
sis is illustrated in Fig. 3 B. In brief, from cells transfected with 
cDNA constructs containing eYFP only, ratio A0 is defined as the 
ratio between the fluorescence excited by light filtered by Cube I 
(FY(Direct)436) and the fluorescence excited by the light passing fil-
ter Cube II (FY500). Namely:
 Ratio A F FY Direct 436
Y
50 00=
( ) .  
Another ratio (Ratio A) was determined from cells cotransfected 
with constructs containing cerulean and eYFP. In this case, the 
cerulean fluorescence by direct excitation was obtained from cells 
expressing cerulean only, and was subtracted from the cerulean–
excitation spectrum obtained from cells coexpressing cerulean 
Figure 2. Intracellular Cd2+ in-
hibition on WT CLC-0 and the 
C212S mutant. (A) Original re-
cording traces of WT CLC-0 in 
various intracellular [Cd2+]. The 
current relaxations at those hy-
perpolarized voltages are caused 
by voltage-dependent closure of 
the fast gate. (B) Normalized 
steady-state current of WT CLC-0 
in different intracellular [Cd2+]: 
0 (black), 30 µM (red), 300 µM 
(green), and 1 mM (purple). 
The initial tail currents after dif-
ferent test voltages in various 
[Cd2+] were all normalized to 
the maximal initial tail current 
in 0 [Cd2+]. (C) Fast-gate Po as a 
function of voltage in the pres-
ence of 0 (black), 30 µM (red), 
100 µM (green), and 300 µM 
(blue) Cd2+, calculated by nor-
malizing the initial tail current 
to the maximal tail current in 
the same [Cd2+]. (Inset) Current 
relaxation time constant of the 
recorded current as those shown 
in A, which is equal to the in-
verse of the sum of the opening 
and the closing rate of the fast gate. The colors representing various [Cd2+] are the same as those in the Po-V plot. (D) Comparing the 
effects of intracellular Cd2+ between WT CLC-0 and the C212S mutant. A test pulse of 60 mV followed by a tail voltage at 100 mV was 
given every 2 s to monitor the Cd2+ inhibition. Current was measured at the end of the tailed pulse when the current reached the steady 
state. Various [Cd2+] were applied at the time indicated by the arrows. Dash line represents zero-current level.
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inside-out patch recordings of WT CLC-0. The problem 
was circumvented by an accidental finding that the mu-
tations of I225W and V490W accelerated the inhibition 
kinetics. Mutations of the corresponding residues in 
CLC-ec1 (I201W/I422W) have been shown previously 
to disrupt the subunit interaction, resulting in func-
tional monomeric CLC-ec1 proteins (Robertson et al., 
2010). However, the I225W/V490W mutant of CLC-0 
remains as a dimer when expressed in HEK293 cells, as 
shown by the FRET experiment in which the FRET ef-
ficiency between a FRET donor and a FRET acceptor 
attached to the I225W/V490W mutant is no less than 
that observed in the WT construct (Fig. 3, C and D). 
Nevertheless, the voltage dependence of the opening of 
the I225W/V490W mutant channel is opposite to that 
of the WT channel: the mutant channel’s open proba-
bility (Po) increases as the membrane voltage hyperpo-
larizes (Fig. 4 A). Moreover, Cd2+ inhibition is now faster 
and more potent: even 1 µM Cd2+ significantly inhibits 
the current (Fig. 4 B).
A full characterization of the Cd2+ sensitivity of 
I225W/V490W is shown in Fig. 5 A, in which the currents 
of the mutant channel in excised membrane patches 
were recorded in various Cd2+ concentrations ([Cd2+]). 
We noticed that Cd2+ appears to have two distinct ef-
fects. First, the voltage-dependent steady-state activation 
electrophoresis. The proteins were then transferred to nitrocel-
lulose papers and detected by anti-Flag antibody (M2 antibody; 
Sigma-Aldrich).
R E S U L T S
Similar to the extracellular effect of Zn2+ on CLC-0 
(Chen, 1998), intracellular Cd2+ can also inhibit the 
channel, although much higher concentrations, at least 
tens of micromolars, are required to generate inhibi-
tion (Fig. 2, A and B). The Po-V curve and the kinetics of 
the fast gating of CLC-0 appear not to be affected by 
intracellular Cd2+ at a concentration range that signifi-
cantly inhibits the channel (Fig. 2 C). Furthermore, the 
inhibition of the channel by Cd2+ is largely suppressed 
by the C212S mutation (Fig. 2 D), which prevents the 
slow gate of CLC-0 from closing (Lin et al., 1999). Col-
lectively, these results suggest that intracellularly applied 
Cd2+ inhibits CLC-0 by modulating the slow gating.
The hypothesis that the intracellular Cd2+ inhibition 
of CLC-0 is mediated by modulating the channel’s slow 
gating is consistent with the findings that the inhibition 
and recovery processes are slow (see Fig. 2 D, top). The 
slow kinetics of the inhibition rendered a precise char-
acterization of the Cd2+ effect technically challenging 
because of relatively short durations of stable excised 
Figure 3. FRET experiments 
of the cerulean (C)- and eYFP 
(Y)-tagged CLC0-TM. (A) Fluores-
cence images of a cell expressing 
C- and Y-tagged CLC0-TM with 
I225W/V490W mutations from 
C (top left) and Y excitation (bot-
tom left). The corresponding 
spectroscopic images (middle) 
were obtained by passing the 
signal through a slit (vertical or-
ange lines). The emission spec-
tra (right) were obtained from 
the upper edge of the spectro-
scopic images (arrows). (B; top) 
Emission spectra from the cell 
in A by C excitation (blue trace) 
and Y excitation (yellow trace). 
Red trace is the standard C emis-
sion spectrum from C excitation. 
Green trace was obtained by 
subtracting the red trace from 
the blue trace. (Bottom) Ratio 
A and Ratio A0 (inset) are plot-
ted against wavelength. (C) Ap-
parent FRET efficiency (Eapp) of 
the C- and Y-tagged CLC0-TM 
against the C/Y intensity ratio. 
Each point represents the Eapp 
from a cell. (D) Apparent FRET 
efficiency of the C- and Y-tagged CLC0-TM with I225W/V490W mutations (red dots). Black dots were from a control experiment in 
which cells were cotransfected with WT CLC-0 and the subunit A2 of the rat olfactory CNG channel. Data points in C and D are fitted 
(solid curves) to Eqs. 3 and 4 of Bykova et al. (2006). In both C and D, significant FRET efficiency (18% for WT and 30% for I225W/
V490W) was observed compared with the control experiment.
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To understand the structural basis of the Cd2+ inhibi-
tion, we searched for the amino acid residues involved 
in forming the Cd2+-binding site. We first tested if cyste-
ine-modifying reagents, such as MTS compounds, could 
affect Cd2+ inhibition because binding of transition 
metal ions in proteins frequently involves cysteine 
(Rulíšek and Vondrásek, 1998). Fig. 6 A shows that the 
Cd2+ inhibition of the I225W/V490W current, monitored 
by a 50-ms voltage pulse from 0 to 100 mV every 2 s, 
was indeed abolished after the patch was treated with 
intracellularly applied 2-(trimethylammonium)ethyl 
MTS (MTSET; Fig. 6 A, left) or 2-sulfonatoethyl MTS 
(MTSES) (Fig. 6 A, right). Consistently, the presence of 
intracellular Cd2+ reduced the effect of MTSET or 
curve of this mutant shifts to more hyperpolarized volt-
ages in low [Cd2+] (<30 µM). Second, higher [Cd2+] 
(such as 1 mM) reduces the maximal level of the chan-
nel activation (Fig. 5 B). Because of the dual effects of 
Cd2+, the dose–response curve of the Cd2+ inhibition 
throughout the entire Cd2+ concentration range cannot 
be fitted to a single Langmuir function. We thus focused 
on the inhibition by low [Cd2+] (up to 300 µM), and nor-
malized the inhibition effect to that induced by 1 mM 
Cd2+. The values of IC50 so obtained were 1, 7, and 204 µM 
at 80, 120, and 160 mV, respectively (Fig. 5 C). 
Therefore, the inhibition of I225W/V490W by Cd2+ is 
voltage dependent; the apparent affinity is decreased 
with more hyperpolarized membrane potentials.
Figure 4. Intracellular Cd2+ inhibition 
of the I225W/V490W double mutant 
of CLC-0. (A) Original recording traces 
(left), steady-state voltage-dependent 
activation curve (middle), and the nor-
malized steady-state I-V curve (right) of 
the I225W/V490W mutant. Data were 
from recording traces with p/4 leak 
subtraction. The dotted line in the left 
panel represents the zero-current level. 
(B) Effects of various intracellular 
[Cd2+] on the steady-state current of the 
I225W/V490W mutant. A test pulse of 
100 mV was given every 2 s, and the 
current was measured at the end of the 
pulse to monitor the Cd2+ inhibition. 
Dotted line represents the zero-current 
level. Cd2+ of various concentrations 
was applied as indicated by the arrows.
Figure 5. Steady-state inhibition of 
the I225W/V490W mutant of CLC-0 
by intracellular Cd2+. (A) Original re-
cording traces in the absence of Cd2+ 
(control) and in the presence of vari-
ous [Cd2+]. (B) Voltage-dependent ac-
tivation curves of I225W/V490W in 
0 (control) and various [Cd2+] based 
on the experiments similar to those 
shown in A. The initial tail current was 
normalized to that obtained after the 
test pulse of 160 mV in the absence 
of Cd2+. Notice that the maximal Po 
of I225W/V490W is reduced at 1 mM 
of Cd2+. (C) Dose–response curves of 
the Cd2+ inhibition of I225W/V490W 
at different voltages (black, 80 mV; 
blue, 120 mV; red, 160 mV). Data 
points were fitted to a Langmuir equa-
tion with an apparent affinity of 1 µM 
(80 mV), 7 µM (120 mV), and 204 
µM (160 mV), respectively.
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C229 (C229S), H231 (H231Y), or both (C229S/H231Y) 
in the background of I225W/V490W indeed suppressed 
the ability of Cd2+ to shift the steady-state activation 
curve (Fig. 7, A–C, respectively). When the C229S muta-
tion was made in the WT CLC-0, the Cd2+ inhibition ef-
fect was also significantly reduced (Fig. 7 D). Likewise, 
the mutation H231Y also reduced the sensitivity of Cd2+ 
inhibition on WT CLC-0 (not depicted). However, the 
reduction of maximal channel activity by high [Cd2+] 
still existed in these mutants (Fig. 7, A–D), suggesting 
that it is mediated by a different mechanism. Our re-
sults thus demonstrate that C229 and H231 form the 
high affinity Cd2+-binding site, where binding of Cd2+ 
MTSES (Fig. 6 B), indicating that at least one cysteine 
forms part of the binding site, so that Cd2+ binding 
would protect the cysteine from MTS modifications.
Among the 12 endogenous cysteines in CLC-0, we 
have shown previously that C229, which is located at the 
dimer interface near the intracellular end of the trans-
membrane domain, can be modified by intracellular 
MTS reagents (Zhang et al., 2010). Interestingly, a histi-
dine residue, H231, is located nearby, raising the possi-
bility that it can act with C229 to coordinate Cd2+ as a 
bidentate ligand (Puljung and Zagotta, 2011). We thus 
tested whether C229 and H231 could both be involved 
in the formation of the Cd2+-binding site. Mutating 
Figure 6. Competition between Cd2+ bind-
ing and the MTS modification in the I225W/
V490W mutant of CLC-0. Current was moni-
tored by a 40-ms test pulse of 100 mV every 
2 s. MTS reagents and Cd2+ were applied or 
washed out at the time points indicated by ar-
rows. (A) Modification of the I225W/V490W 
mutant with intracellular MTSET (left) or 
MTSES (right) suppresses the Cd2+ inhibition 
effect. (B) Cd2+ binding prevents the modifi-
cation by MTSET (left) or MTSES (right) on 
the I225W/V490W mutant.
Figure 7. Mutations of C229 and/or H231 
suppress the Cd2+ effect in shifting the Po-V 
curve of I225W/V490W and WT CLC-0. 
(A–C) Steady-state Po-V curves of I225W/
V490W with the C229S single mutation (A), 
the H231Y single mutation (B), or the C229S/
H231Y double mutations (C) in the presence 
of various [Cd2+]. Notice that the shift of 
the Po-V curve by Cd2+ is abolished, whereas 
the inhibition of the maximal Po at high con-
centrations of Cd2+ is still present. (D) Steady-
state Po-V curves of the C229S mutant on the 
WT background in different [Cd2+].
502 Cadmium modulation in CLC channels
When cysteine and histidine were introduced to the 
corresponding positions in CLC-1 (S294C/Y296H), a 
Cd2+-binding site was created, and the activation of 
CLC-1 could be modulated by intracellular Cd2+ (Figs. 8 
B and 9, A and B). Like the MTS modification of the 
endogenous cysteine (C229) in CLC-0, modification of 
the introduced cysteine (S294C) abolished Cd2+ inhibi-
tion on CLC-1 containing the engineered Cd2+-binding 
site (Fig. 9 C).
shifts the steady-state activation curve of I225W/V490W. 
It is likely that C229 and H231 from both CLC-0 sub-
units together coordinate Cd2+ binding, as these resi-
dues are located near the dimer interface and therefore 
are close to each other (see Fig. 1). The conclusion that 
C229 and H231 form the Cd2+-binding site is further 
supported by experiments from CLC-1. These two resi-
dues are not conserved in CLC-1, which is not sensitive 
to intracellular Cd2+ modulation (Figs. 8 A and 9 A). 
Figure 8. Introducing a cysteine and a histidine 
residue to positions in CLC-1 that correspond 
to C229 and H231 of CLC-0 enables a modula-
tion of CLC-1 by micromolar [Cd2+]. (A) The 
overall channel open probability (Po; top) and 
the common-gate open probability (Poc; bottom) 
of WT CLC-1 as a function of voltage in the ab-
sence (control, black) and presence of 100 µM 
Cd2+ (blue). (B) The Po–V and Poc–V curves of 
the S294C/Y296H mutant of CLC-1 in various in-
tracellular [Cd2+]. C229 and H231 of CLC-0 are 
not conserved in CLC-1, and as expected, 100 µM 
Cd2+ has nearly no effect on WT CLC-1 (Fahlke 
et al., 1998). However, 10 µM Cd2+ significantly 
increases the open probability of the common 
gate (Poc) of the CLC-1 mutant S294C/Y296H. 
Notice the opposite effect of Cd2+ on the open 
probability of CLC-1 (potentiation) compared 
with that of CLC-0 (inhibition).
Figure 9. Suppressing the Cd2+ 
effect in the S294C/Y296H mu-
tant of CLC-1 by intracellular 
MTS reagents. (A) Micromolar 
concentrations of intracellular 
Cd2+ have little effect on the WT 
CLC-1. The current was moni-
tored continuously by a pulse 
of 60 mV followed by a voltage 
step at 100 mV. Intracellular 
Cd2+ was applied (downward ar-
rows) and washed out (upward 
arrows) as indicated. Inset shown 
on the right panel is a compari-
son of two original recording 
traces taken before (black) and 
after (red) the application of 
100 µM Cd2+. (B) Intracellular 
Cd2+ potentiates the current of 
the S294C/Y296H double mu-
tant of CLC-1. Inset on the right 
is a comparison of two original 
recording traces taken before 
(black) and after (red) 100 µM 
[Cd2+]. Notice that the current 
deactivation kinetics at the hy-
perpolarization voltage caused by the closure of the fast gate is not altered by Cd2+, indicating that the effect is not on the fast gating 
of the channel. (C) Potentiation of the S294C/Y296H mutant by intracellular Cd2+ is abolished after modifying the channel with in-
tracellular MTSET, indicating that the introduced cysteine and histidine at the positions of S294 and Y296 form a Cd2+-binding site in 
CLC-1 as well.
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between the transmembrane domain and the cytoplas-
mic domain have been demonstrated in CLC molecules 
(Feng et al., 2010; Bennetts and Parker, 2013), the cyto-
plasmic domain of CLC-0 may influence Cd2+ inhibition. 
We thus tested the intracellular Cd2+ effect on a CLC-0 
Because binding sites for transition metal cations can 
be formed by four cysteine residues (Yellen et al., 1994), 
we tested the effect of Cd2+ on CLC-0 with the H231C 
mutation. Such a CLC-0 construct contains cysteine at 
all four positions of 229 and 231 from two subunits 
(and thus will be called “4C” mutant). In the WT back-
ground, the 4C mutant becomes very sensitive to Cd2+, 
and the Cd2+ inhibition is nearly irreversible (Fig. 10 A, 
top). Cd2+ inhibition of the 4C mutant with I225W/
V490W background mutations, however, is very differ-
ent; the inhibition can be quickly washed out, but with 
the time of patch excision the channel is less and less 
sensitive to Cd2+ (Fig. 10 A, bottom). We suspected that 
this time-dependent reduction of Cd2+ sensitivity might 
result from the formation of a disulfide bond among 
these four cysteine residues after patch excision, which 
could change the oxidation/reduction condition of the 
channel (Zhang et al., 2008). Indeed, Western blots 
shown in Fig. 10 B demonstrate that the monomeric 
band of the 4C mutant in the I225W/V490W back-
ground disappeared after oxidation (Fig. 10 B, right). 
On the other hand, the majority of the 4C mutant in 
the WT CLC-0 background still remained as monomers 
in the SDS gel after copper phenanthroline treatment 
(Fig. 10 B, left). Similar results were observed in a “2C” 
mutant in which cysteine was present only at position 
231 but not at position 229 (Fig. 10 B), suggesting that 
it is the two cysteines at position 231 that form a disul-
fide bond. Thus, through the differences in Cd2+ inhibi-
tion and disulfide bond formation, we demonstrate 
that like the WT Cd2+-binding site, the structure of the 
mutant Cd2+-binding site with four cysteines is changed 
by the I225W/V490W mutations.
Because C229 and H231 are located near the intracel-
lular end of the transmembrane domain and interactions 
Figure 10. Disulfide bond linking two CLC sub-
units. (A) Inhibition of CLC-0 by Cd2+ binding to 
the binding site containing four cysteines in the WT 
CLC-0 background (top) and the dimer interface 
mutant background (DM; bottom). Excised inside-
out patch recordings. The voltage pulse (60 mV 
followed by 100 mV) for monitoring the current 
was given every 2 s, and the current at the end of 
the 100-mV voltage was monitored. Dotted lines, 
zero current level. Horizontal bars indicate the ap-
plication of 10 µM Cd2+. (B) I229W/V490W dimer 
interface mutations (DM) facilitate disulfide bond 
formation in copper phenanthroline (CuP) between 
the two C231 residues. “4C” indicates that all four 
positions at positions 229 and 231 from two subunits 
were cysteine, whereas “2C” contained cysteine only 
at position 231 but not at position 229 (C229S/
H231C). Arrows indicate the monomer of CLC-0, 
which disappeared likely because of a disulfide bond 
formation between the two C231 residues.
Figure 11. Effects of intracellular Cd2+ on the C terminus–
truncated CLC-0 (CLC0-TM). (A) Current of the eYFP-tagged 
CLC0-TM activated by a voltage family from 60 to 160 mV in a 
20-mV voltage step. Excised inside-out patch recordings. Tail 
voltage was 100 mV. (B) Effects of intracellular Cd2+ on the cur-
rent of CLC0-TM monitored by continuously applying a voltage 
pulse of 100 mV (40 ms) every 2 s. Currents at the end of the 
100-mV voltage step are plotted against time. 100 µM Cd2+ was 
applied as indicated by the horizontal red line. (Inset) Compar-
ison of the recording traces before and after Cd2+ application. 
Dashed line indicates the zero-current level.
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application, and plotted the time course of the current 
inhibition by Cd2+ (Fig. 13 A). Fitting the Cd2+ inhibi-
tion time course with an exponential function gives 
the inhibition time constant (on), the inverse of which 
(1/on) is defined as the apparent Cd2+ inhibition rate 
(or apparent on rate), kon. The observation that kon is a 
saturable function of [Cd2+] (Fig. 13 B) suggests that 
Cd2+ inhibition is not a simple bimolecular reaction in-
volving only Cd2+ binding. These results suggest that 
the binding of Cd2+ to the open-state channel may not 
immediately close the channel, and the delay in cur-
rent inhibition upon Cd2+ application could result from 
the conformational change between the open and the 
closed state of this dimer interface mutant.
We have also measured the rate of current recovery 
after Cd2+ washout (apparent off-rate, or koff) using a 
similar two-pulse protocol. The current recovery pro-
cess was well described by a single-exponential function 
(recording traces not depicted). These kinetic mea-
surements of Cd2+ inhibition and recovery were con-
ducted at multiple holding voltages (Fig. 13, C and D). 
The values of the apparent on (in 30 µM Cd2+) and off 
at 0, 40, and 80 mV are compared in Fig. 13 E. Al-
though on is insensitive to the change of membrane 
potential, the value of off decreases as membrane po-
tential becomes more negative. Therefore, the lower 
apparent affinity of Cd2+ inhibition at more negative 
voltages on the I225W/V490W mutant results mostly 
from a faster off-rate by membrane hyperpolariza-
tion. Collectively, these results suggest a state-dependent 
mutant in which the C-terminal region of the channel 
after residue 530 is replaced with a fluorescent protein. 
As reported previously (Bykova et al., 2006), this CLC-0 
mutant (abbreviated as “CLC0-TM”) generates hyper-
polarization-activated currents (Fig. 11 A). Interest-
ingly, Cd2+ did not inhibit but potentiated this mutant 
(Fig. 11 B), suggesting that the cytoplasmic domain of 
the CLC channel may also be involved in the intra-
cellular Cd2+ modulation, likely through its interaction 
with the transmembrane domain.
To gain further insights into the Cd2+ modulation 
mechanism, we studied the kinetics of Cd2+ inhibition 
on I225W/V490W of CLC-0, taking advantage of the 
faster kinetics of Cd2+ inhibition in this mutant. Fig. 12 A 
illustrates a two-pulse protocol used to examine the rate 
of Cd2+ inhibition by measuring the current of the 
I225W/V490W mutant elicited by a 100-mV voltage 
pulse before (first pulse) and after the patch was 
exposed to Cd2+ for a certain amount of time (second 
pulse). Combining multiple recording traces from the 
same patch generates the time course of Cd2+ inhibi-
tion (Fig. 12 B). It is worth noticing that there appears 
to be a delay of the current inhibition because the 
current recorded after applying Cd2+ for 0.2 s is almost 
the same as that before the Cd2+ application. This delay 
has little voltage dependence (Fig. 12 C), but as [Cd2+] 
is increased, the delay is shortened (Fig. 12 D). To 
analyze the kinetics of Cd2+ inhibition like that shown 
in Fig. 12 B, we normalized the current induced by 
the second voltage pulse to the current before Cd2+ 
Figure 12. Rate of Cd2+ inhibition 
(on rate) on the I225W/V490W mu-
tant of CLC-0. (A) Original recording 
traces from one patch using the two-
pulse (to 100 mV) protocol described 
in Materials and methods. [Cd2+] = 
100 µM. Vhold = 40 mV. (B) Combin-
ing the recording traces from A shows 
the time course of Cd2+ inhibition. Dot-
ted curve is the single-exponential fit 
of the current amplitude elicited at 
various time spots except the one at 
0.2 s (the second pulse). Notice the 
delay of Cd2+ inhibition shown by com-
paring the second pulse (in red) with 
the entire inhibition time course. (C) 
Delay of current inhibition upon Cd2+ 
application obtained at different volt-
ages. [Cd2+] = 300 µM. Solid curve is a 
voltage-dependent exponential fit for 
the relation between the delay time and 
the voltage, with an estimated electric 
distance of 0.025. n = 7. (D) [Cd2+] 
dependence of the delay of current in-
hibition. Vm = 80 mV. Data points are 
the average of five to eight experiments 
(mean ± SEM).
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The apparent affinity of intracellular Cd2+ on WT 
CLC-0 is quite low—tens to hundreds of micromolars of 
[Cd2+] is required for an observable effect. However, 
the potency of Cd2+ is significantly enhanced by trypto-
phan substitutions of I225 and V490, which correspond 
to dimer interface residues I201 and I422, respectively, 
in CLC-ec1. The I201W/I422W mutation in CLC-ec1 
disrupts dimer architecture, leading to the formation of 
CLC monomers (Robertson et al., 2010). The corre-
sponding mutations in CLC-0, however, do not separate 
the two channel subunits as indicated by a high FRET 
efficiency between the FRET donor and acceptor tagged 
to the C termini of the transmembrane domains (Fig. 3). 
The formation of a disulfide bond between the two cys-
teine residues at position 231 further demonstrates 
a dimeric CLC molecule in the I290W/V490W back-
ground mutations (Fig. 10). Despite the fact that CLC-0 
with I225W/V490W mutations remains as a dimer, the 
mutant channel’s voltage-dependent gating properties 
have been inverted from that of the WT channel (Fig. 4 A). 
It is conceivable that introducing bulky tryptophan side 
chains into the dimer interface alters the interaction 
between the two CLC subunits, thus increasing appar-
ent affinity and kinetics of Cd2+ inhibition (Fig. 4 B), 
and facilitating disulfide bond formation between cyste-
ines at position 231 (Fig. 10).
A closer examination of the Cd2+ inhibition on the 
I225W/V490W mutant reveals that intracellular Cd2+ 
binding of Cd2+ to the channel; Cd2+ binding to the 
closed state of the channel is energetically more favored 
than the binding to the open state.
D I S C U S S I ON
Transition metal ions have been widely used to study 
the structure–function relationship of ion channels. In 
the Shaker K+ channel, for example, the state-dependent 
affinity change of extracellular Cd2+ inhibition revealed 
a structural change on the external mouth of the chan-
nel during the slow (C-type) inactivation (Yellen et al., 
1994). Intracellularly applied Cd2+ was also used to show 
that the activation gate of the Shaker K+ channel can be 
trapped in the open state when an intersubunit metal 
bridge is formed (Holmgren et al., 1998). CLC-0 and 
CLC-1 have been found to be inhibited by Zn2+ or Cd2+ 
applied from the extracellular side (Rychkov et al., 
1997; Chen, 1998), and extracellular Zn2+ is known to 
inhibit WT CLC-0 by facilitating the closure of the slow 
gate (Chen, 1998). We found in the present study that 
the inhibition of WT CLC-0 by intracellular Cd2+ is likely 
mediated by a modulation of the slow gating of CLC-0 
as well because intracellular Cd2+ has little effect on the 
fast gating of the channel (Fig. 2 C), and because the 
inhibition is largely suppressed by the C212S mutation 
(Fig. 2 D), which prevents the slow gate of CLC-0 from 
closing (Lin et al., 1999).
Figure 13. Voltage dependence 
of the inhibition and recovery 
kinetics of the Cd2+ modulation 
of the I225W/V490W mutant of 
CLC-0. (A) Time course of cur-
rent inhibition by various [Cd2+] 
(in micromolars) at 40 mV. 
(B) Inverse of the time constant 
of Cd2+ inhibition (kon = 1/on) 
as a function of [Cd2+]. The val-
ues of on were obtained from 
single-exponential fits as in A. 
(C) Averaged time course for 
the inhibition by 30 µM Cd2+ at 
0, 40, and 80 mV. Data points 
were calculated by normalizing 
the current in various [Cd2+] to 
the control current ([Cd2+] = 0). 
(D) Time course of the current 
recovery from Cd2+ inhibition. 
Data points were obtained by 
normalizing the current recov-
ered after Cd2+ was washed out 
to that before the application 
of Cd2+. (E) Time constants of 
the inhibition (on) and recovery 
(off) as a function of membrane 
voltage. Time constants were ob-
tained by fitting the data points 
in C and D with single-exponen-
tial functions.
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subunits covalently poses little impact on the Cl trans-
port function (Nguitragool and Miller, 2007). Similarly, 
the fast gating of CLC-0 and CLC-1 is not affected by 
restricting molecular motions at the dimer interface 
with Cd2+ (Figs. 2 and 9). This is consistent with the ac-
cepted concept that the Cl/H+ exchange cycle of CLC-
ec1 and the fast gating of CLC channels are homologous, 
mediated by molecular motions (for example, swinging 
of the glutamate side chain) confined in individual sub-
units. Coordinating opening and closing of the two Cl 
pathways requires the slow/common gating mechanism 
that enables the cross talk of the two subunits through 
the dimer interface. Cd2+ binding or the introduction of 
bulky residues at the dimer interface would perturb 
such a cross talk and thus modulate slow/common gat-
ing of CLC channels. It is possible that mutation of 
I225W and V490W speeds up the inactivation of CLC-0 
(closure of the slow gate), explaining the faster kinetics 
of Cd2+ inhibition in the I225W/V490W double mutant 
than in the WT channel. Interestingly, Cd2+ binding in-
hibits the current of WT CLC-0 and I225W/V490W but 
potentiates the current of CLC0-TM (Fig. 11) and the 
CLC-1 mutant S294C/Y296H (Figs. 8 and 9). The dif-
ferent consequences of Cd2+ binding (potentiation vs. 
inhibition of the current) may result from the differ-
ence between the cross talk of the two subunits in these 
various channels. Another possibility is that the alloste-
ric interactions between the Cd2+-binding site and the 
C-terminal cytoplasmic domain are different in these 
channels. It will await further studies to understand the 
different functional consequences of Cd2+ modulations 
in CLC-0, CLC-1, and the C terminus–truncated CLC 
channel.
If C229 and H231 of CLC-0 are located at the intracel-
lular end of the transmembrane domain, like their cor-
responding residues R205 and Q207 in CLC-ec1 (Fig. 1), 
it is expected that the Cd2+ site would be outside the 
transmembrane electric field, and thus Cd2+ binding 
should be voltage independent. Indeed, the apparent 
on-rate of Cd2+ is voltage independent (Fig. 13 E). 
However, the apparent Cd2+ affinity is lower at more hy-
perpolarized voltages (Fig. 5 C) because membrane 
hyperpolarization (which favors the opening of the 
I225W/V490W mutant) accelerates Cd2+ dissociation 
(Fig. 13, D and E). The voltage dependence of the 
apparent off-rate thus suggests a state-dependent Cd2+ 
inhibition; namely, Cd2+ binding to the open state is en-
ergetically less favorable than the binding to the closed 
state. Furthermore, Cd2+ inhibition shows an apprecia-
ble delay (Fig. 12) and the apparent on-rate of Cd2+ in-
hibition is a saturable function of [Cd2+] (Fig. 13 B), 
both corroborating the idea that Cd2+ binding to the 
open-state channel cannot immediately shut the pore. 
Instead, it will require a subsequent molecular event, 
likely a conformational change associated with slow gat-
ing, to close the channel.
appears to have two effects. At low micromolar [Cd2+], 
the mutant channel’s steady-state activation curve is 
shifted to more hyperpolarized voltages by Cd2+. We ob-
served a competition between intracellular Cd2+ inhibi-
tion and MTS modification (Fig. 6), a clear indication 
that like many other transition metal-binding proteins, 
the amino acid cysteine is directly involved in forming 
the Cd2+-binding site. Further mutagenesis experiments 
showed that the mutation of C229S, H231Y, or both 
abolishes the Cd2+-induced shift of the steady-state acti-
vation curve in WT CLC-0 and in the I225W/V490W 
mutant (Fig. 7), indicating that the high affinity Cd2+ 
inhibition is mediated through the binding site formed 
by C229 and H231. On the other hand, the maximal 
open probability of these mutants was still inhibited by 
Cd2+ at the millimolar concentrations, suggesting that 
the low affinity Cd2+ inhibition may be mediated by a 
different mechanism.
The residues C229 and H231 of CLC-0 correspond to 
R205 and Q207, respectively, in CLC-ec1, which are in 
close proximity to the same residues in the partner sub-
unit (Fig. 1). As seen in many metalloproteins, tetrahe-
dral is a preferred coordination arrangement for Cd2+ 
binding, usually involving four cysteine/histidine resi-
dues (Rulíšek and Vondrásek, 1998). Therefore, it is 
likely that the Cd2+ site in CLC-0 is formed by two sub-
units, each contributing two chelators from C229 and 
H231 to bind Cd2+. These cysteine and histidine resi-
dues, however, are not conserved in CLC-1, thus ex-
plaining the fact that WT CLC-1 is insensitive to 
intracellular Cd2+, as shown in Figs. 8 A and 9 A, and 
also reported previously by others (Rychkov et al., 1997; 
Fahlke et al., 1998). In this study, we are able to con-
struct a Cd2+-binding site in CLC-1 by engineering 
S294C/Y296H mutations to mimic the Cd2+ site in CLC-
0. This strategy yields a CLC-1 mutant whose activity is 
modulated by low micromolar intracellular Cd2+, al-
though the consequence of the Cd2+ modulation is po-
tentiation but not inhibition of the channel current! 
Such Cd2+ effect, again, is abolished by pretreating the 
channel with intracellular MTS reagents (Fig. 9 C), indi-
cating that a Cd2+-binding site is indeed created. Previous 
studies have indicated an interaction of the transmem-
brane domain and the C-terminal cytoplasmic domain 
of CLC proteins (Feng et al., 2010; Bennetts and Parker, 
2013). Experiments in Fig. 11 show that removing the 
C-terminal region of CLC-0 changes the Cd2+ effect 
from inhibition to potentiation. Thus, the interaction 
of the transmembrane domain with the C-terminal cyto-
plasmic domain as well as the subunit interaction at the 
dimer interface are both involved in intracellular Cd2+ 
modulation of CLC-0.
These experimental results thus allow us to compare 
the functional roles of subunit interactions between 
CLC channels and bacterial CLC proteins. It was dem-
onstrated previously that cross-linking the two CLC-ec1 
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